Radiation Oncology Team

Richard Tuli, MD
Medical Director, Radiation Oncology, Tampa General Hospital
Deputy Director, TGH Cancer Institute

Richard Tuli, MD, PhD, is the director of radiation oncology at Tampa General Hospital as well as a professor and chair of radiation oncology at USF Health Morsani College of Medicine. Prior to joining TGH, he served as associate attending and director of developmental therapeutics at the NCI-designated comprehensive cancer center, Memorial Sloan Kettering Cancer Center in New York, and associate professor and clinical director of radiation oncology at Cedars-Sinai Medical Center in Los Angeles. As a leader in advancing the field of radiation oncology, Dr. Tuli focuses on providing a comprehensive, multi-disciplinary and personalized experience for patients through a combination of cutting-edge technology, novel treatments and developing a connection between the patient and provider.

   

Clayton Alonso, MD
Radiation Oncologist, TGH Cancer Institute

Dr. Clayton Elliott Alonso is a highly accomplished radiation oncologist. Prior to joining Tampa General Hospital, he served since 2019 at Advanced Cancer Treatment Centers in Brooksville, Florida. Dr. Alonso’s journey began with his education at the University of Virginia School of Medicine, where he graduated with honors and was inducted into the prestigious Alpha Omega Alpha honor society. He completed his transitional year at the University of Pittsburgh Medical Center Mercy in 2015, before embarking on his residency in Radiation Oncology at the University of Virginia School of Medicine, where he was recognized as Chief Resident from 2018 to 2019. During his residency, Dr. Alonso received several accolades, including the Constable/Agarwal Award and the Clinical Excellence Award, highlighting his dedication and exceptional performance in the field.

Doctor Brian Collins Headshot

Brian T. Collins, MD, FCCP
Radiation Oncologist, TGH Cancer Institute

Dr. Brian T. Collins is a board-certified radiation oncologist with significant clinical experience in treating brain, breast and lung cancers. Regarded as a world-renowned expert in CyberKnife® radiotherapy technology, Dr. Collins specializes in cutting-edge radiation oncology techniques and tools. Dr. Collins has frequently contributed to scientific journals, books and publications in areas of his expertise. He is a Fellow in the American College of Chest Physicians (ACCP) and a member of numerous related professional organizations.

Sean Collins is a board-certified radiation oncologist with the TGH Cancer Institute 

Sean P. Collins, MD, FCCP
Radiation Oncologist, TGH Cancer Institute
Vice Chair, Faculty Affairs


Dr. Sean P. Collins is a highly accomplished radiation oncologist, most recently serving as the director of the CyberKnife Prostate Program at MedStar Georgetown University Hospital in Washington, D.C. With board certification from the American Board of Radiology in Radiation Oncology, Dr. Collins has dedicated over two decades to advancing the treatment of prostate cancer. Specifically, he has treated over 2500 men with prostate cancer utilizing the CyberKnife. He has been at the forefront of innovative radiation therapies, earning him recognition as a Washingtonian Top Doctor since 2015.

 

Rodney Ellis, MD
Radiation Oncologist, TGH Cancer Institute
Vice Chair, Radiation Oncology Operations

Dr. Rodney Ellis is a distinguished Radiation Oncologist specializing in adult malignancies, with a focus on genitourinary cancers like prostate, bladder, and renal cancer. He earned his Medical Doctor Degree from Northeast Ohio Medical University.

Dr. Ellis has held faculty positions as Associate and later Professor in Radiation Oncology, Urology, and Radiology at Case Western Reserve University. He also held the esteemed position of Inaugural Chair of the Department of Radiation Oncology for the Penn State University/Penn State Cancer Institute and the Milton Hershey Medical Center, making significant contributions to the Penn State Health Cancer Network.

Mohamed Khattab is a board-certified radiation oncologist with the TGH Cancer Institute 

Mohamed Khattab, MD
Radiation Oncologist, TGH Cancer Institute

Dr. Mohamed Khattab is a radiation oncologist at Tampa General Hospital and a faculty member at the USF Health Morsani College of Medicine. Dr. Khattab specializes in treating patients with brain and spine tumors and has a unique expertise in the treatment of benign neuropsychiatric diseases and complex pain syndromes using stereotactic radiosurgery. After earning his medical degree from the Johns Hopkins School of Medicine, he began his training in neurosurgery at New York University before transitioning to radiation oncology at Vanderbilt University, where he served as chief resident.

Dr. Heyoung McBride is a radiation oncologist at the TGH Cancer Institute.

Heyoung McBride, MD, MS
Radiation Oncologist, TGH Cancer Institute

Dr. Heyoung L. McBride is a board-certified radiation oncologist with expertise in brachytherapy and stereotactic radiosurgery. She earned her medical degree from The University of Kansas School of Medicine, completed her residency at the University of Arizona Health Sciences Center and was an ASTRO Research Fellow at the University of Arizona Cancer Center. Most recently, Dr. McBride served as co-medical director of Lovelace Cancer Center and medical director of Radiation Oncology at Lovelace Health
System, while also having held a faculty position as clinical associate professor at the University of Arizona College of Medicine Phoenix.

Alexander Engelman, MD
Radiation Oncologist, TGH Cancer Institute

Dr. Alexander Engelman, a native of Tampa, is a radiation oncologist with knowledge treating all cancer sites. He has experience with advanced treatments including external beam radiotherapy, brachytherapy, partial breast irradiation, Gamma Knife and CyberKnife radiosurgery, and stereotactic body radiotherapy. Dr. Engelman is a graduate of the Georgetown University School of Medicine. For residency training, he attended the University of Maryland Medical Center and the Maryland Proton Treatment Center with additional time at St. Jude Children’s Research Hospital.